Algert Global LLC Sells 102,705 Shares of Quanterix Corporation $QTRX

Key Points

• Algert Global LLC has reduced its holdings in Quanterix Corporation by 68.6%, selling 102,705 shares and now owning approximately 0.12% of the company, valued at $306,000.
• Insider transactions include significant purchases by directors, with William P. Donnelly acquiring 93,113 shares and David R. Walt acquiring 131,869 shares, reflecting their confidence in the company's future.
• Quanterix reported a quarterly EPS of ($0.47), missing analyst expectations, and also announced a bleak FY 2025 guidance, with analysts predicting a consensus rating of "Hold."

Algert Global LLC decreased its stake in shares of Quanterix Corporation (NASDAQ:QTRX - Free Report) by 68.6% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 46,988 shares of the company's stock after selling 102,705 shares during the quarter. Algert Global LLC owned about 0.12% of Quanterix worth $306,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently modified their holdings of the company. Ameriprise Financial Inc. lifted its holdings in shares of Quanterix by 111.3% in the 4th quarter. Ameriprise Financial Inc. now owns 3,205,928 shares of the company's stock worth $34,079,000 after purchasing an additional 1,688,680 shares in the last quarter. Millennium Management LLC lifted its holdings in shares of Quanterix by 6.0% in the 4th quarter. Millennium Management LLC now owns 2,185,101 shares of the company's stock worth $23,228,000 after purchasing an additional 122,969 shares in the last quarter. Easterly Investment Partners LLC lifted its holdings in shares of Quanterix by 38.8% in the 1st quarter. Easterly Investment Partners LLC now owns 1,325,620 shares of the company's stock worth $8,630,000 after purchasing an additional 370,625 shares in the last quarter. Dimensional Fund Advisors LP lifted its holdings in shares of Quanterix by 0.7% in the 4th quarter. Dimensional Fund Advisors LP now owns 893,645 shares of the company's stock worth $9,500,000 after purchasing an additional 6,099 shares in the last quarter. Finally, Russell Investments Group Ltd. lifted its stake in Quanterix by 51.1% during the 1st quarter. Russell Investments Group Ltd. now owns 606,787 shares of the company's stock valued at $3,950,000 after acquiring an additional 205,311 shares in the last quarter. Institutional investors and hedge funds own 86.48% of the company's stock.

Quanterix Stock Up 0.1%

Shares of QTRX traded up $0.01 during mid-day trading on Friday, hitting $4.55. 326,363 shares of the company's stock traded hands, compared to its average volume of 783,832. The firm has a market capitalization of $211.21 million, a P/E ratio of -2.50 and a beta of 1.07. The business's 50-day moving average price is $5.65 and its 200-day moving average price is $6.00. Quanterix Corporation has a 1 year low of $4.05 and a 1 year high of $15.85.

Quanterix (NASDAQ:QTRX - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The company reported ($0.47) earnings per share for the quarter, missing the consensus estimate of ($0.41) by ($0.06). The firm had revenue of $24.48 million during the quarter, compared to analysts' expectations of $29.73 million. Quanterix had a negative return on equity of 18.41% and a negative net margin of 56.04%. Quanterix has set its FY 2025 guidance at EPS. Sell-side analysts anticipate that Quanterix Corporation will post -0.98 earnings per share for the current fiscal year.

Insider Buying and Selling at Quanterix

In other news, Director William P. Donnelly purchased 93,113 shares of Quanterix stock in a transaction that occurred on Friday, June 6th. The shares were bought at an average cost of $5.44 per share, with a total value of $506,534.72. Following the completion of the purchase, the director directly owned 139,094 shares in the company, valued at approximately $756,671.36. This trade represents a 202.50% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director David R. Walt bought 123,990 shares of the company's stock in a transaction on Friday, June 13th. The stock was bought at an average cost of $6.14 per share, for a total transaction of $761,298.60. Following the completion of the acquisition, the director directly owned 1,866,933 shares of the company's stock, valued at approximately $11,462,968.62. This represents a 7.11% increase in their position. The disclosure for this purchase can be found here. Over the last ninety days, insiders purchased 463,113 shares of company stock worth $2,625,444. 6.90% of the stock is owned by insiders.

Analysts Set New Price Targets

Several equities analysts have weighed in on QTRX shares. Canaccord Genuity Group restated a "hold" rating and set a $5.00 price objective (down from $12.00) on shares of Quanterix in a research note on Monday, August 11th. Wall Street Zen downgraded Quanterix from a "hold" rating to a "sell" rating in a research report on Thursday, May 22nd. One research analyst has rated the stock with a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat, Quanterix has an average rating of "Hold" and a consensus price target of $11.75.

Quanterix Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.